Riley Kirk, Ph.D
CEO and Cofounder of NAPNAP (The Netwok of Applied Pharmacognosy)Dr. Riley Kirk is a natural products chemist, cannabis researcher, and science communicator with a Ph.D. in Pharmaceutical Sciences specializing in Natural Product Chemistry. She is the co-founder of the nonprofit (NAP) Network of Applied Pharmacognosy, host of the Bioactive Podcast, and author of Reefer Wellness. Through her work in research, education, and media, Dr. Kirk focuses on advancing evidence-based cannabis science and bridging the gap between academia, industry, and consumers.
Delivery Matters: Engineering Bioavailability, Emulsions, and Precision Inhalation
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and u
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and ultimately whether patients stick with a product. An oral edible may take an hour to work and lose mu
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and ultimately whether patients stick with a product. An oral edible may take an hour to work and lose much of its potency to first-pass metabolism. An inhaled dose hits in minutes but demands precision to stay reliable. Topicals and water-soluble emulsions open entirely new performance and credibility p
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and ultimately whether patients stick with a product. An oral edible may take an hour to work and lose much of its potency to first-pass metabolism. An inhaled dose hits in minutes but demands precision to stay reliable. Topicals and water-soluble emulsions open entirely new performance and credibility profiles. For executives, product developers, and researchers, mastering these differences is now central to cannabis business growth strategies.
This session unpacks the formulation science separating ordinary products from clinically credible ones. We'll connect bioavailability, emulsion technology, and precision inhalation to current cannabis market trends and the cannabis innovation reshaping shelves and pipelines. The shift into precision formulation isn't just chemistry — it's one of the clearest cannabis industry opportunities for brands ready to lead.
